NIRS Ticagrelor Evaluation

NCT02282332 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Ticagrelor

Sponsor

Medstar Health Research Institute

Collaborators

[object Object]